PL375388A1 - Przeciwdrobnoustrojowe pochodne azabicykliczne, zawierające je środki i ich zastosowanie - Google Patents

Przeciwdrobnoustrojowe pochodne azabicykliczne, zawierające je środki i ich zastosowanie

Info

Publication number
PL375388A1
PL375388A1 PL03375388A PL37538803A PL375388A1 PL 375388 A1 PL375388 A1 PL 375388A1 PL 03375388 A PL03375388 A PL 03375388A PL 37538803 A PL37538803 A PL 37538803A PL 375388 A1 PL375388 A1 PL 375388A1
Authority
PL
Poland
Prior art keywords
derivates
aza
bicyclic
antimicrobial
compositions
Prior art date
Application number
PL03375388A
Other languages
English (en)
Inventor
Benoit Ledoussal
Xiufeng Eric Hu
Ji-In Kim Almstead
Jeffrey Lyle Gray
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL375388A1 publication Critical patent/PL375388A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL03375388A 2002-07-31 2003-07-18 Przeciwdrobnoustrojowe pochodne azabicykliczne, zawierające je środki i ich zastosowanie PL375388A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40001402P 2002-07-31 2002-07-31

Publications (1)

Publication Number Publication Date
PL375388A1 true PL375388A1 (pl) 2005-11-28

Family

ID=31715691

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375388A PL375388A1 (pl) 2002-07-31 2003-07-18 Przeciwdrobnoustrojowe pochodne azabicykliczne, zawierające je środki i ich zastosowanie

Country Status (17)

Country Link
US (1) US6900224B2 (pl)
EP (1) EP1532137A2 (pl)
JP (1) JP2005536532A (pl)
KR (1) KR20050026074A (pl)
CN (1) CN1671690A (pl)
AU (1) AU2003259169A1 (pl)
BR (1) BR0313420A (pl)
CA (1) CA2493146A1 (pl)
IL (1) IL166041A0 (pl)
MA (1) MA27467A1 (pl)
MX (1) MXPA05001180A (pl)
NO (1) NO20051082L (pl)
NZ (1) NZ537203A (pl)
PL (1) PL375388A1 (pl)
RU (1) RU2005105337A (pl)
WO (1) WO2004014893A2 (pl)
ZA (1) ZA200500877B (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321042T3 (es) * 1997-09-15 2009-06-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas, composiciones y usos de las mismas.
ATE395920T1 (de) * 1999-12-28 2008-06-15 Teikoku Seiyaku Kk Wirkstoffe gegen pruritus zum äusserlichen gebrauch
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
US7354916B2 (en) * 2003-04-07 2008-04-08 Cylene Pharmaceuticals Substituted quinobenzoxazine analogs
KR100944600B1 (ko) * 2003-04-07 2010-02-25 사일린 파마슈티칼스, 인크 치환된 퀴노벤족사진 유사체
EP1610795A4 (en) * 2003-04-07 2007-10-24 Cylene Pharmaceuticals Inc HETEROCYCLIC SUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHPYRIDINE ANALOGUE
EP1802306A2 (en) * 2004-09-17 2007-07-04 Cylene Pharmaceuticals, Inc. Quinolone analog as cell proliferation inhibitors
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
WO2007110835A2 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
PL2001862T3 (pl) * 2006-03-28 2011-09-30 Warner Chilcott Co Llc Jabłczany oraz odmiany polimorficzne kwasu (3S,5S)-7-[3-amino-5-metylo-piperydynylo]-1-cyklopropylo-1,4-dihydro-8-metoksy-4-okso-3-chinolinokarboksylowego
EP1999106B1 (en) * 2006-03-28 2012-06-27 TaiGen Biotechnology Co., Ltd. A hydride reduction process for preparing quinolone intermediates
US7723355B2 (en) * 2006-11-20 2010-05-25 Bristol-Myers Squibb Company 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
CN101888780B (zh) * 2007-10-05 2014-08-13 生华生物科技股份有限公司 喹诺酮类似物及其相关方法
NZ588898A (en) * 2008-07-01 2012-09-28 Taigen Biotechnology Co Ltd Use of nemonoxacin for treating antibiotic-resistant staphylococcus aureus infection
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
EP2376477A4 (en) * 2008-12-15 2012-08-08 Taigen Biotechnology Co Ltd STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES
CN102093260B (zh) * 2009-12-14 2014-03-05 太景生物科技股份有限公司 哌啶衍生物的立体有择合成
CA3005730A1 (en) 2015-11-20 2017-05-26 Senhwa Biosciences, Inc. Combination therapy of tetracyclic quinolone analogs for treating cancer
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
WO2017107089A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor
ES2789756T3 (es) 2015-12-23 2020-10-26 Merck Sharp & Dohme Moduladores alostéricos de 6,7-dihidro-5H-pirrolo[3,4-b]piridin-5-ona del receptor de acetilcolina muscarínico M4
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112840A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112842A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor
WO2019000238A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000236A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000237A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
TWI884912B (zh) 2018-02-15 2025-06-01 生華生物科技股份有限公司 喹啉酮類似物及其鹽、組合物及其使用方法
US11332444B2 (en) 2018-04-25 2022-05-17 Bayer Animal Health Gmbh Method for the hydrolysis of quinolonecarboxylic esters

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0395177A (ja) 1988-05-19 1991-04-19 Chugai Pharmaceut Co Ltd 新規キノロンカルボン酸誘導体
JPH09503783A (ja) * 1993-10-14 1997-04-15 アボツト・ラボラトリーズ キノリジノン型化合物
EP0871628A1 (en) * 1995-06-06 1998-10-21 Abbott Laboratories Quinolizinone type compounds
KR100241673B1 (ko) * 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
ES2321042T3 (es) * 1997-09-15 2009-06-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas, composiciones y usos de las mismas.
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
YU55902A (sh) * 2000-01-24 2006-01-16 Warner-Lambert Company 3-aminohinazolin-2,4-dioni kao antibakterijska sredstva
NZ525571A (en) 2000-12-14 2004-09-24 Procter & Gamble Antimicrobial quinolones

Also Published As

Publication number Publication date
EP1532137A2 (en) 2005-05-25
NZ537203A (en) 2007-02-23
IL166041A0 (en) 2006-01-15
RU2005105337A (ru) 2006-01-20
WO2004014893A3 (en) 2004-04-08
US6900224B2 (en) 2005-05-31
BR0313420A (pt) 2005-06-28
AU2003259169A1 (en) 2004-02-25
ZA200500877B (en) 2006-02-20
MA27467A1 (fr) 2005-08-01
CN1671690A (zh) 2005-09-21
CA2493146A1 (en) 2004-02-19
JP2005536532A (ja) 2005-12-02
NO20051082L (no) 2005-04-29
US20040038975A1 (en) 2004-02-26
MXPA05001180A (es) 2005-05-16
KR20050026074A (ko) 2005-03-14
WO2004014893A2 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
ZA200500877B (en) Antimicrobial aza-bicyclic derivatives, their compositions and uses.
EP1902724A3 (en) Antimicrobial compositions
ZA200602885B (en) Antimicrobial compositions and methods
HUP0600027A3 (en) Antiseptic compositions, methods and systems
AU2003262747A8 (en) Compounds, compositions, and methods
EP1542699A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
EP1503993A4 (en) COMPOUNDS, METHODS AND COMPOSITIONS
AU2003236527A8 (en) Compounds, compositions, and methods
EP1513820A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
EP1553931A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
AU2003299612A8 (en) Compounds, compositions and methods
AU2003288133A1 (en) Herbidical composition
IL164581A0 (en) Compounds, compositions and methods
HUP0500871A3 (en) 5-aryltetrazole compounds, compositions thereof and their use
AU2003277079A8 (en) Compounds, compositions, and methods
EP1594849A4 (en) COMPOUNDS, COMPOSITIONS, AND METHODS
AU2003290507A8 (en) Compounds, compositions and methods
IL167936A0 (en) Compounds, compositions,and methods
GB0307695D0 (en) Compounds,compositions and processes
GB0222259D0 (en) Antimicrobial compositions
ZA200501387B (en) Antimicrobial compositions.
GB2406053B (en) Antimicrobial composition
GB0328845D0 (en) Antimicrobial composition
EP1708735A4 (en) ANTIMICROBIAL COMPOSITION
GB0314469D0 (en) Antimicrobial compositions and uses thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)